RHEUMATOID ARTHRITIS TREATMENT CLINIC BUSINESS PLAN

I. Executive Summary

Company Description

Lakeview Rheumatology Center (named for Chicago’s Lakeview neighborhood) is a specialty outpatient clinic opening in 2026 that operates in the healthcare sector, focused exclusively on the diagnosis and treatment of rheumatoid arthritis (RA). We deliver integrated medical, diagnostic, infusion, and rehabilitative services under one roof. Our core offerings are board-certified rheumatology care, on-site biologic infusions administered by trained infusion nurses, targeted physical therapy, and personalized remission-focused care plans designed to restore mobility and quality of life.

The clinic’s main activities are patient evaluation, lab and imaging diagnostics, biologic therapy administration, and coordinated rehabilitation. What sets us apart is a single-visit care path that combines infusion treatment with same-day physical therapy planning and outcome tracking, plus a team-based model that keeps the same clinicians involved over time. We target adults in the Chicago RA community who need specialty care and advanced biologic therapies. Short-term goals: open in 2026 and reach consistent weekly infusion capacity within six months. Long-term goals: achieve regional center-of-excellence status and sustain long-term remission outcomes for a growing patient panel.

Problem

Millions of Americans with rheumatoid arthritis face a fragmented care pathway that delays diagnosis and treatment, accelerates joint damage, increases chronic pain and disability, and creates significant psychological stress for patients and caregivers.

Current care is split across separate specialists—rheumatologists, physical therapists, infusion centers—without a central coordinator, and there is no widely available centralized hub that manages medical, diagnostic, and rehabilitative needs; our Chicago clinic (launching 2026) will integrate these services under one roof to fill that gap and deliver coordinated, long-term treatment plans focused on remission and restored mobility.

Solution

Millions of Americans with rheumatoid arthritis face a fragmented healthcare system that delays treatment and worsens joint damage; patients must visit multiple locations for consultations, infusions, and therapy, producing uncoordinated care, more pain, and poorer outcomes. This clinic addresses that gap by concentrating services for RA in one location.

Integrated care center in Chicago delivers rheumatology, diagnostic musculoskeletal ultrasound, on-site physical and occupational therapy, and a specialized infusion suite for biologic treatments, with coordinated multidisciplinary care plans and medication management to simplify the treatment journey and support long-term remission. One clear result: all core RA services under one roof to reduce care delays and improve outcomes.

Mission Statement

We provide the highest level of specialized, integrated care for people living with rheumatoid arthritis, committed to achieving long-term remission and restored quality of life through clinical excellence and compassionate support. By focusing exclusively on RA, we deliver personalized, coordinated care, education, and community resources that empower patients and drive continuous innovation in treatment.

Key Success Factors

Focused clinical specialization and a scalable, insurer-backed operating model drive clinical trust and financial returns.

• 100% specialization in rheumatoid arthritis: builds unmatched clinical expertise and patient trust.
• Integrated service model: multiple revenue streams and superior patient convenience.
• Major health-insurer partnerships: broad access and reliable reimbursement.
• Scalable clinical team (2 to 6 rheumatologists by 2030): enables rapid market-share capture.
• Financial targets (43.89% IRR; 25.21% ROE): ensure long-term sustainability and investor appeal.

Financial Summary

The clinic projects strong early profitability on a fee-for-service model, with rapid growth and immediate payback.

Financial requirements: minimum cash $846,000 (Feb-26); breakeven Jan-26; full payback in 1 month; IRR 43.89%.

Overall outlook: high-margin, rapidly scaling clinic with strong investor returns.

Funding Requirements

We seek $1,151,000 to fund clinic setup and provide a minimum operating cash reserve ahead of a Feb-2026 launch.

One-line: Target funding combines founder equity and specialized medical-practice financing to raise $1,151,000 by Feb-26.

Financial snapshot: Year 1 revenue of $2,318,000 and EBITDA $1,115,000; Year 5 revenue $12,327,000 and EBITDA $9,286,000. We expect breakeven in Jan-2026 and a full payback within one month; projected Return on Equity is 25.21% on a fee-for-service model.